Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapiesZijun Y. Xu‐Monette, Ken H. Young, Yi Xia et al.|Journal for ImmunoTherapy of Cancer|2019Cited by 28